Financials Norofert S.A.

Equities

NRF

ROHQGW108MX2

Agricultural Chemicals

End-of-day quote Bucharest S.E. 06:00:00 2024-07-11 pm EDT 5-day change 1st Jan Change
4 RON 0.00% Intraday chart for Norofert S.A. +0.76% -10.51%

Valuation

Fiscal Period: December 2023
Capitalization 1 76.65
Enterprise Value (EV) 1 114.2
P/E ratio -19.4 x
Yield -
Capitalization / Revenue 1.74 x
EV / Revenue 2.59 x
EV / EBITDA 62.2 x
EV / FCF -100,832,444 x
FCF Yield -0%
Price to Book 3.58 x
Nbr of stocks (in thousands) 17,148
Reference price 2 4.470
Announcement Date 4/30/24
1RON in Million2RON
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 9.959 14.9 25.08 52.97 73.44 44.08
EBITDA 1 5.191 - 9.075 11.57 16.01 1.836
EBIT 1 4.672 5.287 7.966 9.647 14.79 0.003703
Operating Margin 46.91% 35.47% 31.77% 18.21% 20.14% 0.01%
Earnings before Tax (EBT) 1 4.641 5.211 4.817 8.469 12.23 -3.927
Net income 1 4.471 4.622 3.803 7.089 10.57 -3.949
Net margin 44.89% 31.01% 15.17% 13.38% 14.39% -8.96%
EPS - 0.2880 0.2370 - 0.6162 -0.2303
Free Cash Flow - - - - -4.864 -1.133
FCF margin - - - - -6.62% -2.57%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/29/20 4/29/20 6/24/21 4/24/23 4/24/23 4/30/24
1RON in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 0.98 0.37 14.1 21.6 34.2 37.6
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 0.1881 x - 1.552 x 1.867 x 2.137 x 20.46 x
Free Cash Flow - - - - -4.86 -1.13
ROE (net income / shareholders' equity) - 45.5% 22.9% 37.4% 46.6% -17.1%
ROA (Net income/ Total Assets) - 18% 15.1% 11.7% 13.1% 0%
Assets 1 - 25.73 25.22 60.51 80.37 -127,391
Book Value Per Share - 0.9900 1.090 - 1.450 1.250
Cash Flow per Share - 0.0500 0.0200 - 0.1000 0.0200
Capex - - - - 6.51 2.9
Capex / Sales - - - - 8.87% 6.59%
Announcement Date 4/29/20 4/29/20 6/24/21 4/24/23 4/24/23 4/30/24
1RON in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. NRF Stock
  4. Financials Norofert S.A.